The objectives of the Media Preparation and Glassware Washing Shared Resource are to provide an efficient and reliable distribution of the product media at the lowest possible cost to the investigator while offering a wide variety of purchasing choices and to provide an efficient washing facility that will result in cost savings to the investigator and, at the same, will meet research requirements of clean and sterile glassware. The Media shared resource offers the research investigator two options: 1) Media prepared to follow specifications additives and pH parameters, as required by the investigator. Raw powdered media and special additives are provided by each individual investigators Preparation includes a step by step mixing sterile filtration, bottling and capping of the product. After bottling , media is label-identified and refrigerated until delivery to the investigator. 2) Media ordered from Life Technologies Cell Culture Products by individual researchers and processed by the shared resource. Purchased items are accepted from Life Technologies and distributed to the various laboratories from a central location by the CCC delivery service. Flyers are sent out bimonthly to all CCC members and each working lab is e-mailed quarterly updating the services offered. The Glassware Washing shared resource operates two separate washing facilities for 52 members within the CCC. There has been steady growth in amount of glassware washed and the number of members served. Each facility has an automatic washer with variable timing and multiple rinse cycles, autoclaves, automatic pipette stuffer and drying ovens. Additional services provided are pickup of dirty glassware from, and delivery of clean glassware from, and delivery of clean glassware to, investigator laboratories, hand rinsing, hot air and steam sterilization, acid washing, waste autoclaving, clean glassware storage, and the availability of a Type 1 pure water production system for laboratory usage. These facilities also act as a resource for specialized washing procedures.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-26
Application #
6430841
Study Section
Project Start
2001-03-07
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
O'Brien, Susan M; Jaglowski, Samantha; Byrd, John C et al. (2018) Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials. JAMA Oncol 4:712-716
Guo, Sijin; Piao, Xijun; Li, Hui et al. (2018) Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor. Methods 143:121-133
Sadowski, Abbey R; Gardner, Heather L; Borgatti, Antonella et al. (2018) Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma. BMC Vet Res 14:250
Barredo, Julio C; Hastings, Caroline; Lu, Xiamin et al. (2018) Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study. Pediatr Blood Cancer 65:e26928
Kim, So-Youn; Nair, Devi M; Romero, Megan et al. (2018) Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies. Cell Death Differ :
Yadav, Marshleen; Song, Feifei; Huang, Jason et al. (2018) Ocimum flavone Orientin as a countermeasure for thrombocytopenia. Sci Rep 8:5075
Siegel, Marni B; He, Xiaping; Hoadley, Katherine A et al. (2018) Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest 128:1371-1383
White, Brian S; Lanc, Irena; O'Neal, Julie et al. (2018) A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer J 8:35
Owen, Dwight; Chaft, Jamie E (2018) Immunotherapy in surgically resectable non-small cell lung cancer. J Thorac Dis 10:S404-S411
Barajas, Juan M; Reyes, Ryan; Guerrero, Maria J et al. (2018) The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer. Sci Rep 8:9105

Showing the most recent 10 out of 2602 publications